ZIOPHARM ONCOLOGY INC
ZIOPHARM ONCOLOGY INC
Aktie · US98973P1012 · ZIOP · A0JMYA (XNAS)
Übersicht Finanzkennzahlen
Kein Kurs
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - - - 0,00 % 0,00 % -74,46 %

Firmenprofil zu ZIOPHARM ONCOLOGY INC Aktie

ZIOPHARM Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing a portfolio of immuno-oncology therapies to treat patients with cancer. The company develops Sleeping Beauty platform, which is based on the non-viral genetic engineering of immune cells using a transposon/transposase system to engineer T-cells outside of the body for infusion; and Controlled IL-12 to stimulate expression of interleukin 12 or IL-12, a master regular of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells. Its product candidates include T cell receptor + T therapies to target solid tumors; chimeric antigen receptor + T cell therapies targeting CD19 for hematologic malignancies; and Ad-RTS-hIL-12 plus veledimex, a gene delivery system to regulate production of IL-12 to treat patients with recurrent glioblastoma multiforme in adults. The company has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; a patent license agreement with the National Cancer Institute; and a cooperative research and development agreement with the National Cancer Institute. ZIOPHARM Oncology, Inc. is headquartered in Boston, Massachusetts.

Investierte Fonds

Folgende Fonds haben in investiert: ZIOPHARM ONCOLOGY INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
11,89
Anteil (%)
0,03 %

Unternehmensdaten

Name ZIOPHARM ONCOLOGY INC
Firma ZIOPHARM Oncology, Inc.
Symbol ZIOP
Website https://ziopharm.com
Heimatbörse XNAS NASDAQ
WKN A0JMYA
ISIN US98973P1012
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Laurence Cooper
Marktkapitalisierung 208 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse One First Avenue Parris Building 34, Navy Yard Plaza, 02129 Boston
IPO Datum 2004-08-20

Aktien-Splits

Datum Split
24.08.2005 1:40

Ticker Symbole

Name Symbol
NASDAQ ZIOP

Weitere Aktien

Investoren die ZIOPHARM ONCOLOGY INC die halten, haben auch folgende Aktien im Depot:
A.P.MOELLER 24/36 MTN
A.P.MOELLER 24/36 MTN Anleihe
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
CRYOPORT INC
CRYOPORT INC Aktie
ELECTRONIC ARTS INC
ELECTRONIC ARTS INC Aktie
INTEL CORP
INTEL CORP Aktie
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NXP SEMICONDUCTORS NV
NXP SEMICONDUCTORS NV Aktie
SEER INC - CLASS A
SEER INC - CLASS A Aktie
THE MIDDLEBY CORP
THE MIDDLEBY CORP Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025